Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
Designing optimal (neo)adjuvant therapy is a crucial aspect of the treatment of non-small-cell lung carcinoma (NSCLC). Standard methods of chemotherapy, radiotherapy, and immunotherapy represent effective strategies for treatment. However, in some cases with high metastatic activity and high levels...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a9212fe2fd9443cd854b6088bd96b44c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|